Skip to main content

Advertisement

SpringerLink
Log in

Reducing the Risks for Contrast-Induced Nephropathy

  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Contrast-induced nephropathy (CIN) is one of the most serious adverse events associated with the use of contrast media (CM). Patients who develop this complication can have increased morbidity, higher rates of mortality, lengthy hospital stays, and poor long-term outcomes. Although CIN cannot be eliminated, the chances of developing this condition can be reduced by using appropriate prevention strategies. An important first step to reduce the chance of CIN is to identify risk factors associated with this condition. Patients with a previously elevated serum creatinine level, especially when secondary to diabetic nephropathy, are at great risk for developing CIN. Other patient-related risk factors include concurrent use of nephrotoxic medications, dehydration, congestive heart failure, age greater than 70 years, and probably the presence of diabetes mellitus even if serum creatinine is normal. Adequate hydration is widely accepted as an important prophylactic measure for preventing CIN, but the optimal hydration regimen is still debatable. The risk of CIN increases with greater doses of CM, as well as with the type of CM used. A high-osmolar CM poses a greater risk of CIN than does a low-osmolar CM and, as recent but limited data suggest, the use of an iso-osmolar CM is less nephrotoxic than a low-osmolar CM in patients with renal impairment following intra-arterial procedures, although this finding needs to be verified in future clinical studies. Pharmacologic agents such as calcium channel blockers, dopamine, atrial natriuretic peptide, fenoldopam, prostaglandin E1, and endothelin receptor antagonist have not been proven effective against CIN development. Controversies still exist on the possible effectiveness of theophylline and N-acetylcysteine. Simple strategies for the prevention of CIN in at-risk patients are reviewed and unproven interventions are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Morcos SK, Thomsen HS, Webb JA (1999) Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 9:1602–1613

    Article  PubMed  CAS  Google Scholar 

  2. Mehran R, Aymong ED, Nikolsky E, et al. (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44:1393–1399

    Article  PubMed  Google Scholar 

  3. Levy EM, Viscoli CM, Horwitz RI (1996) The effect of acute renal failure on mortality. A cohort analysis. JAMA 275:1489–1494

    PubMed  CAS  Google Scholar 

  4. McCullough PA, Wolyn R, Rocher LL, et al. (1997) Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103:368–375

    Article  PubMed  CAS  Google Scholar 

  5. Dangas G, Iakovou I, Nikolsky E, et al. (2005) Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 95:13–19

    Article  PubMed  Google Scholar 

  6. Powe NR, Moore RD, Steinberg EP (1993) Adverse reactions to contrast media: factors that determine the cost of treatment. AJR Am J Roentgenol 161:1089–1095

    PubMed  CAS  Google Scholar 

  7. Morcos SK (2004) Prevention of contrast media nephrotoxicity–the story so far. Clin Radiol 59:381–389

    PubMed  CAS  Google Scholar 

  8. Lee JK, Warshauer DM, Bush WH, Jr., et al. (1995) Determination of serum creatinine level before intravenous administration of iodinated contrast medium. A survey. Invest Radiol 30:700–705

    PubMed  CAS  Google Scholar 

  9. Thomsen HS, Morcos SK (2005) In which patients should serum creatinine be measured before iodinated contrast medium administration? Eur Radiol 15:749–754

    Article  PubMed  Google Scholar 

  10. Choyke PL, Cady J, DePollar SL, et al. (1998) Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients? Tech Urol 4:65–69

    PubMed  CAS  Google Scholar 

  11. Rudnick MR, Goldfarb S, Wexler L, et al. (1995) Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 47:254–261

    PubMed  CAS  Google Scholar 

  12. Bartholomew BA, Harjai KJ, Dukkipati S, et al. (2004) Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 93:1515–1519

    Article  PubMed  Google Scholar 

  13. Cavusoglu E, Chhabra S, Marmur JD, et al. (2004) The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Minerva Cardioangiol 52:419–432

    PubMed  CAS  Google Scholar 

  14. Alamartine E, Phayphet M, Thibaudin D, et al. (2003) Contrast medium-induced acute renal failure and cholesterol embolism after radiological procedures: incidence, risk factors, and compliance with recommendations. Eur J Intern Med 14:426–431

    Article  PubMed  Google Scholar 

  15. King B, Segal A, Berg G, et al. (2004) Manual on Contrast Media. American College of Radiology. Reston, Virginia

    Google Scholar 

  16. Thomsen HS, Dorph S, Larsen S, et al. (1995) Urine profiles and kidney histology after ionic and nonionic radiologic and magnetic resonance contrast media in rats with cisplatin nephropathy. Acad Radiol 2:675–682

    PubMed  CAS  Google Scholar 

  17. Gami AS, Garovic VD (2004) Contrast nephropathy after coronary angiography. Mayo Clin Proc 79:211–219

    PubMed  Google Scholar 

  18. Maeder M, Klein M, Fehr T, et al. (2004) Contrast nephropathy: Review focusing on prevention. J Am Coll Cardiol 44:1763–1771

    Article  PubMed  Google Scholar 

  19. Trivedi HS, Moore H, Nasr S, et al. (2003) A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 93:C29–34

    Article  PubMed  CAS  Google Scholar 

  20. Mueller C, Buerkle G, Buettner HJ, et al. (2002) Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162:329–336

    PubMed  CAS  Google Scholar 

  21. Merten GJ, Burgess WP, Gray LV, et al. (2004) Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291:2328–2334

    Article  PubMed  CAS  Google Scholar 

  22. Gruberg L, Mintz GS, Mehran R, et al. (2000) The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36:1542–1548

    Article  PubMed  CAS  Google Scholar 

  23. Freeman RV, O’Donnell M, Share D, et al. (2002) Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 90:1068–1073

    Article  PubMed  Google Scholar 

  24. Barrett BJ, Carlisle EJ (1993) Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188:171–178

    PubMed  CAS  Google Scholar 

  25. Aspelin P, Aubry P, Fransson SG, et al. (2003) Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348:491–499

    Article  PubMed  CAS  Google Scholar 

  26. Waybill MM, Waybill PN (2001) Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol 12:3–9

    PubMed  CAS  Google Scholar 

  27. Ferrone M (2004) Pharmacotherapeutic options to prevent radiocontrast-induced acute renal failure. Formulary 39:163–185

    CAS  Google Scholar 

  28. Idée J, Lancelot E, Pines E, et al. (2004) Prophylaxis of iodinated contrast media-induced nephropathy. A pharmacological point of view. Invest Radiol 39:155–170

    Google Scholar 

  29. Russo D, Testa A, Della Volpe L, et al. (1990) Randomised prospective study on renal effects of two different contrast media in humans: protective role of a calcium channel blocker. Nephron 55:254–257

    PubMed  CAS  Google Scholar 

  30. Russo D, Minutolo R, Cianciaruso B, et al. (1995) Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol 6:1451–1458

    PubMed  CAS  Google Scholar 

  31. Kapoor A, Sinha N, Sharma RK, et al. (1996) Use of dopamine in prevention of contrast induced acute renal failure–a randomised study. Int J Cardiol 53:233–236

    Article  PubMed  CAS  Google Scholar 

  32. Hall KA, Wong RW, Hunter GC, et al. (1992) Contrast-induced nephrotoxicity: the effects of vasodilator therapy. J Surg Res 53:317–320

    Article  PubMed  CAS  Google Scholar 

  33. Hans B, Hans SS, Mittal VK, et al. (1990) Renal functional response to dopamine during and after arteriography in patients with chronic renal insufficiency. Radiology 176:651–654

    PubMed  CAS  Google Scholar 

  34. Hans SS, Hans BA, Dhillon R, et al. (1998) Effect of dopamine on renal function after arteriography in patients with pre-existing renal insufficiency. Am Surg 64:432–436

    PubMed  CAS  Google Scholar 

  35. Weisberg LS, Kurnik PB, Kurnik BR (1993) Dopamine and renal blood flow in radiocontrast-induced nephropathy in humans. Ren Fail 15:61–68

    PubMed  CAS  Google Scholar 

  36. Gleeson T, O’Dwyer J, Bulugahapitiya S, et al. (2004) Contrast-induced nephropathy. Br J Cardiol (Acute Interv Cardiol) 11:AIC 53–AIC 61

    Google Scholar 

  37. Weisberg LS, Kurnik PB, Kurnik BR (1994) Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 45:259–265

    PubMed  CAS  Google Scholar 

  38. Kurnik BR, Allgren RL, Genter FC, et al. (1998) Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 31:674–680

    PubMed  CAS  Google Scholar 

  39. Stone GW, McCullough PA, Tumlin JA, et al. (2003) Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA 290:2284–2291

    Article  PubMed  CAS  Google Scholar 

  40. Allaqaband S, Tumuluri R, Malik AM, et al. (2002) Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheter Cardiovasc Interv 57:279–283

    PubMed  Google Scholar 

  41. Koch JA, Plum J, Grabensee B, et al. (2000) Prostaglandin E1: a new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media? PGE1 Study Group. Nephrol Dial Transplant 15:43–49

    PubMed  CAS  Google Scholar 

  42. Wang A, Holcslaw T, Bashore TM, et al. (2000) Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int 57:1675–1680

    PubMed  CAS  Google Scholar 

  43. Ix JH, McCulloch CE, Chertow GM (2004) Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis. Nephrol Dial Transplant 19:2747–2753

    PubMed  CAS  Google Scholar 

  44. Hoffmann U, Fischereder M, Kruger B, et al. (2004) The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 15:407–410

    PubMed  CAS  Google Scholar 

  45. Tepel M, van der Giet M, Schwarzfeld C, et al. (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343:180–184

    Article  PubMed  CAS  Google Scholar 

  46. Kay J, Chow WH, Chan TM, et al. (2003) Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 289:553–558

    PubMed  CAS  Google Scholar 

  47. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW (2002) Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol 89:356–358

    Article  PubMed  CAS  Google Scholar 

  48. Shyu KG, Cheng JJ, Kuan P (2002) Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 40:1383–1388

    Article  PubMed  CAS  Google Scholar 

  49. Birck R, Krzossok S, Markowetz F, et al. (2003) Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 362:598–603

    Article  PubMed  CAS  Google Scholar 

  50. Kshirsagar AV, Poole C, Mottl A, et al. (2004) N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. J Am Soc Nephrol 15:761–769

    Article  PubMed  CAS  Google Scholar 

  51. Fishbane S, Durham JH, Marzo K, et al. (2004) N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol 15:251–260

    Article  PubMed  CAS  Google Scholar 

  52. Nguyen-Ho P, Dzavik V, Seidelin P, et al. (2003) N-Acetylcysteine does not prevent long-term clinical events despite reducing periprocedural contrast-associated nephropathy. Circulation 108 (Suppl IV):445. Abstract 2047

    Google Scholar 

  53. Briguori C, Colombo A, Violante A, et al. (2004) Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J 25:206–211

    PubMed  CAS  Google Scholar 

  54. Lehnert T, Keller E, Gondolf K, et al. (1998) Effect of haemodialysis after contrast medium administration in patients with renal insufficiency. Nephrol Dial Transplant 13:358–362

    PubMed  CAS  Google Scholar 

  55. Vogt B, Ferrari P, Schonholzer C, et al. (2001) Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 111:692–698

    Article  PubMed  CAS  Google Scholar 

  56. Morcos S, Thomsen H, Webb J, et al. (2004) Dialysis and contrast media. JBR-BTR 87:87–87

    Google Scholar 

  57. Marenzi G, Marana I, Lauri G, et al. (2003) The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 349:1333–1340

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Ospedale di Cattinara, University of Trieste, Strada di Fiume, 34149, Trieste, Italy

    Fulvio Stacul

Authors
  1. Fulvio Stacul
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fulvio Stacul.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stacul, F. Reducing the Risks for Contrast-Induced Nephropathy. Cardiovasc Intervent Radiol 28 (Suppl 2), S12–S18 (2005). https://doi.org/10.1007/s00270-005-0197-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-005-0197-7

Keywords

Search

Navigation